BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19472090)

  • 1. Expression of MET in alveolar soft part sarcoma.
    Jun HJ; Lee J; Lim DH; Park JO; Ahn G; Seo SW; Sung KS; Lim DH; Yoo KH; Choi YL
    Med Oncol; 2010 Jun; 27(2):459-65. PubMed ID: 19472090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of ASPL-TFE3 fusion gene by reverse transcriptase polymerase chain reaction in paraffin-embedded tumor tissues of alveolar soft part sarcoma].
    Pang LJ; Li F; Chang B; Hu WH; Lu TC; Li XX; Li HA; Jiang JF
    Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):508-12. PubMed ID: 15634444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
    Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
    Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: useful diagnostic tools in cases with unusual histological features.
    Williams A; Bartle G; Sumathi VP; Meis JM; Mangham DC; Grimer RJ; Kindblom LG
    Virchows Arch; 2011 Mar; 458(3):291-300. PubMed ID: 21279521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Histogenesis and Diagnostic Strategy Using Immunoassay and RT-PCR in Alveolar Soft Part Sarcoma.
    Ju X; Sun K; Liu R; Li S; Abulajiang G; Zou H; Lan J; Ren Y; Jiang J; Liang W; Pang L; Li F
    Pathol Oncol Res; 2018 Jul; 24(3):593-600. PubMed ID: 28766250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alveolar soft part sarcoma: a bimarker diagnostic strategy using TFE3 immunoassay and ASPL-TFE3 fusion transcripts in paraffin-embedded tumor tissues.
    Pang LJ; Chang B; Zou H; Qi Y; Jiang JF; Li HA; Hu WH; Chen YZ; Liu CX; Zhang WJ; Li F
    Diagn Mol Pathol; 2008 Dec; 17(4):245-52. PubMed ID: 18382356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
    Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
    Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma.
    Hoshino M; Ogose A; Kawashima H; Izumi T; Hotta T; Hatano H; Morita T; Otsuka H; Umezu H; Yanoma S; Tsukuda M; Endo N
    Cancer Genet Cytogenet; 2009 Apr; 190(2):75-80. PubMed ID: 19380023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
    Schoolmeester JK; Carlson J; Keeney GL; Fritchie KJ; Oliva E; Young RH; Nucci MR
    Am J Surg Pathol; 2017 May; 41(5):622-632. PubMed ID: 28009610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition.
    Tsuda M; Davis IJ; Argani P; Shukla N; McGill GG; Nagai M; Saito T; LaƩ M; Fisher DE; Ladanyi M
    Cancer Res; 2007 Feb; 67(3):919-29. PubMed ID: 17283122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas.
    Aulmann S; Longerich T; Schirmacher P; Mechtersheimer G; Penzel R
    Histopathology; 2007 Jun; 50(7):881-6. PubMed ID: 17543078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.
    Argani P; Lal P; Hutchinson B; Lui MY; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2003 Jun; 27(6):750-61. PubMed ID: 12766578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASPL-TFE3 translocation in vulvovaginal alveolar soft part sarcoma.
    Jabbour MN; Seoud M; Al-Ahmadie H; Abdul-Karim FW; Zaatari GS
    Int J Gynecol Pathol; 2014 May; 33(3):263-7. PubMed ID: 24681737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting cytomorphology, including unusual features and clinical scenarios of 8 cases of alveolar soft part sarcoma with TFE3 immunohistochemical staining in 7 cases.
    Rekhi B; Rao V; Ramadwar M
    Cytopathology; 2021 Jan; 32(1):20-28. PubMed ID: 32853443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of primary alveolar soft part sarcoma of the uterine cervix and a review of the literature.
    Hasegawa K; Ichikawa R; Ishii R; Oe S; Kato R; Kobayashi Y; Kuroda M; Udagawa Y
    Int J Clin Oncol; 2011 Dec; 16(6):751-8. PubMed ID: 21519815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alveolar Soft Part Sarcoma.
    Jaber OI; Kirby PA
    Arch Pathol Lab Med; 2015 Nov; 139(11):1459-62. PubMed ID: 26516944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript.
    Tsuji K; Ishikawa Y; Imamura T
    Hum Pathol; 2012 Mar; 43(3):356-63. PubMed ID: 21835426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatic analysis of patient-derived ASPS gene expressions and ASPL-TFE3 fusion transcript levels identify potential therapeutic targets.
    Covell DG; Wallqvist A; Kenney S; Vistica DT
    PLoS One; 2012; 7(11):e48023. PubMed ID: 23226201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
    Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.